Article
Tranexamic acid is safe and effective in patients with heterozygous factor V Leiden mutation during total joint arthroplasty.
Archives of orthopaedic and trauma surgery - 1 Feb 2023
Levent Ali, Kose Ozkan, Linke Philip, Gehrke Thorsten, Citak Mustafa
Abstract excerpt
INTRODUCTION: Patients with an inherent hypercoagulable state are at a higher risk of venous thromboembolism (VTE) following total joint arthroplasty (TJA). Further administration of tranexamic acid (TXA) during TJA may increase the risk of VTE in these high-risk patients. There is no study that specifically analyzes the safety and efficacy of TXA during TJA in patients with factor V Leiden (FVL) mutation;...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
